In this week’s episode, Carolyn Magill, CEO and board member for real-world analytics and evidence firm Aetion, speaks with MM&M’s executive editor, Marc Iskowitz. She offers her perspective on how real world evidence (RWE) is finding its footing with pharma, including an update on its RCT Duplicate collaboration with the FDA, where she sees synthetic trials ultimately carving out a niche, and how to ensure that patient privacy needs are met.
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
